Receipts from 10 x SR- aGvHD treatments will be in region of $7-8 million. Enough kick-start to then roll on from there.
No CR needed here I would think.
SI said partnership is needed to go Heart or Back as the footprint is too big to go alone.
Where I could possibly see a need for a small CR is during on-going negotiations that would look better for MSB armed with a healthy bank balance?
- Forums
- ASX - By Stock
- MSB
- Ann: Proposed issue of securities - MSB
MSB
mesoblast limited
Add to My Watchlist
1.92%
!
$1.79

Ann: Proposed issue of securities - MSB, page-36
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
-0.035(1.92%) |
Mkt cap ! $2.306B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $11.91M | 6.671M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 44994 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 28695 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 44994 | 1.790 |
1 | 53149 | 1.785 |
6 | 82839 | 1.780 |
1 | 17489 | 1.775 |
4 | 82576 | 1.770 |
Price($) | Vol. | No. |
---|---|---|
1.800 | 28695 | 2 |
1.805 | 6652 | 2 |
1.810 | 66208 | 7 |
1.815 | 59694 | 4 |
1.820 | 25818 | 3 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online